Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

1 passage

referencesuptodate· REFERENCES· item f39_1_39958

REFERENCES DiSepio D, Malhotra M, Chandraratna R, et al, "Retinoic Acid Receptor–Nuclear Factor–Interleukin 6 Antagonism: A Novel Mechanism of Retinoid-Dependent Inhibition of a Keratinocyte Hyperproliferative Differentiation Marker," J Biol Chem , 1997, 272(41):25555-9. [PubMed 9325272 ] Menter A, Gottlieb A, Feldman SR,, et al, "Guidelines of Care for the Management of Psoriasis and Psoriatic Arthritis: Section 1. Overview of Psoriasis and Guidelines of Care for the Treatment of Psoriasis With Biologics," J Am Acad Dermatol , 2008, 58(5):826-50. [PubMed 18423260 ] Menter A, Korman NJ, Elmets CA, et al, "Guidelines of Care for the Management of Psoriasis and Psoriatic Arthritis: Section 4. Guidelines of Care for the Management and Treatment of Psoriasis With Traditional Systemic Agents," J Am Acad Dermatol , 2009, 61(3):451-85. [PubMed 19493586 ] National Institute for Occupational Safety and Health (NIOSH), "NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012." Available at file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf . Accessed January 21, 2013. Saurat JH, "Retinoids and Psoriasis: Novel Issues in Retinoid Pharmacology and Implications for Psoriasis Treatment," J Am Acad Dermatol , 1999, 41(3 Pt 2):S2-6. [PubMed 10459139 ] Topic 9250 Version 42.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [0502-115.25.216.6-3DB58A19CA-S244013.14]